NY-VIACOMCBS
ViacomCBS Networks International (VCNI), a division of ViacomCBS Inc. (NASDAQ: VIAC), has today confirmed the departure of one of its longest serving executives, Pierluigi Gazzolo, who will step down from his role as President, Streaming and Studios for VCNI at the end of this month to focus on other interests.
During Gazzolo’s tenure as President of Streaming and Studios for VCNI, he successfully established the content proposition, team and go to market strategy for the international launch of Paramount+ and expanded the roadmap for Pluto TV internationally.
VCNI Streaming Leadership
Reporting to David Lynn, President and CEO of VCNI, and working closely with Tom Ryan, President & CEO of ViacomCBS Streaming, Kelly Day, Chief Operating Officer of VCNI, will take over leadership of the division’s streaming business as President of Streaming and COO of VCNI. In this new role, Day will have oversight of the international roll-out of Paramount+, a new premium SVOD service due to launch in 2021 across Australia, Latin America, and the Nordics; as well as the ongoing expansion of Pluto TV, following its successful launch in Latin America.
Regarding Day’s expanded remit, Lynn added, “We are in the fortunate position of going from strength to strength with this transition. With a truly global streaming organization, it’s a pivotal moment in the evolution of our streaming strategy, with the expansion of Paramount+ and Pluto TV, both of which are critical to our future growth. Kelly has an enviable track record of launching and growing streaming businesses and has added a layer of extraordinary digital expertise to our management team in a short space of time. Now, also, working closely with Tom Ryan, I’m confident Kelly will accelerate our transition to becoming a more digitally-led business, while seizing our global streaming opportunity.”
ViacomCBS International Studios Leadership
ViacomCBS Studios International (VIS) will supply original content to the new Paramount+ service in some markets, while continuing to supply scripted, comedy and reality series to VCNI’s free and pay TV networks as well as third party streamers and broadcasters.
Also, reporting to Lynn, JC Acosta, who oversees VCNI’s operations in Latin America and Canada as President, VCN Americas, will take on additional responsibility as President, ViacomCBS International Studios.
Lynn added, “One of our biggest achievements in recent years has been the formation and expansion of VIS, which really couldn’t have happened without Pier’s vision. In the past year, under Pier’s leadership he doubled the global development slate, setting VCNI up for continued global success in the studios arena.”
“Now with JC’s expertise in production and development, coupled with his drive and dedication its incredibly reassuring that JC will take over leadership of VIS,” said Lynn. “Given JC’s intimate understanding of our Studios business, his connections and his knowledge of the international content market, we couldn’t be better positioned for continued growth.”
Gazzolo’s Tenure
Paying tribute to Gazzolo, Lynn said, “While he will hate to be labelled as a veteran, there’s no better word to describe someone who has dedicated so much of his career to our company and who has benefited it so much with his wisdom and experience. He’s a brilliant all-rounder who has played in many positions for our team, but always with the same outstanding results. It’s typical of Pier’s commitment that he’s stayed to oversee a seamless handover to Kelly and JC, even though he’s been signaling his interest in pursuing his own projects for some time. I can’t thank him enough for his contribution to our business over many years. I know everyone at VCNI will join me in genuinely wishing him well in his future endeavors.”
Gazzolo commented, “I’ve grown up with this amazing company. From MTV Latino, to MTV Networks to Viacom International Media Networks to post merger ViacomCBS Networks International. I’ve been honored to grow and evolve with ViacomCBS, and I’m immensely grateful to have worked across so many regions and divisions at the most dynamic media company in the world. I have benefited tremendously from having worked with unparalleled leaders and mentors, throughout my tenure, but especially in the latest chapter of my term. Most importantly I’ve created wonderful close friendships in my 27 years with the company – and those will continue long after I leave the building.”
About Pierluigi Gazzolo
Prior to taking up his current role as President, Streaming and Studios in November 2019, Pierluigi Gazzolo was President, Americas for Viacom International Media Networks, which was renamed as VCNI after the ViacomCBS merger in December last year.
Based in Miami, he oversaw a marked expansion of the company’s operations across Spanish-speaking Latin America and Brazil, spearheaded by two key acquisitions – ownership of Argentina’s leading free-to-air broadcaster, Telefe (2016), and a majority stake in Brazilian comedy producer, Porta dos Fundos (2017). Combining Telefe’s studios business and Porta dos Fundos with VIMN’s existing production activities in the region, Gazzolo formed VIS and secured its first sales to both Netflix and Amazon Prime, as well as a host of other deals with broadcasters and streamers across the region. Under his leadership, VIS has expanded its production activities in the UK, Europe, and Asia.
At the same time as leading the company’s operations in Latin America, Gazzolo continued to lead Nickelodeon internationally, giving him oversight of this critical brand in all markets outside the U.S. In this role, he oversaw an increase in international supply to Nickelodeon’s global content pipeline with locally developed shows being remade for global distribution, including Talia in the Kitchen and Every Witch Way.
Previously, Gazzolo was Chief Operating Officer for VIMN (2011 to 2014) and its predecessor MTV Networks International (2009 to 2011), reporting in both roles to Bob Bakish, who is now CEO, ViacomCBS Inc. Before 2009, he held several different roles with the company including serving as President of MTV Networks Latin America.
ViacomCBS Networks International:
ViacomCBS Networks International, a unit of ViacomCBS Inc. (NASDAQ: VIAC), comprises many of the world’s most iconic entertainment brands, including Network 10, Channel 5, Telefe, Viacom 18, ViacomCBS International Studios, Nickelodeon, MTV, Comedy Central, BET, Paramount Network and Pluto TV. In addition to offering innovative streaming services and digital video products, ViacomCBS Networks International provides powerful capabilities in production, distribution and advertising solutions for partners on five continents and across more than 180 countries.
VIAC-IR
View source version on businesswire.com: https://www.businesswire.com/news/home/20201020005683/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse
Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release
AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release
Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
